BACKGROUND: Advanced prostate cancer is currently treated with androgen deprivation therapy (ADT). ADT initially results in tumor regression; however, all patients eventually relapse with castration-resistant prostate cancer. New approaches to delay the progression of prostate cancer to castration resistance are in desperate need. This study addresses whether targeting Heat shock protein 90 (HSP90) regulation of androgen receptor (AR) can inhibit prostate cancer progression to castration resistance. METHODS: The HSP90 inhibitor 17-AAG was injected intraperitoneally into nude mice bearing LuCaP35 xenograft tumors to determine the effect of HSP90 inhibition on prostate cancer progression to castration resistance and host survival. RESULTS: Administration of 17-AAG maintained androgen-sensitivity, delayed the progression of LuCaP35 xenograft tumors to castration resistance, and prolonged the survival of host. In addition, 17-AAG prevented nuclear localization of endogenous AR in LuCaP35 xenograft tumors in castrated nude mice. CONCLUSIONS: Targeting Hsp90 or the mechanism by which HSP90 regulates androgen-independent AR nuclear localization and activation may lead to new approaches to prevent and/or treat castration-resistant prostate cancer.
BACKGROUND:Advanced prostate cancer is currently treated with androgen deprivation therapy (ADT). ADT initially results in tumor regression; however, all patients eventually relapse with castration-resistant prostate cancer. New approaches to delay the progression of prostate cancer to castration resistance are in desperate need. This study addresses whether targeting Heat shock protein 90 (HSP90) regulation of androgen receptor (AR) can inhibit prostate cancer progression to castration resistance. METHODS: The HSP90 inhibitor 17-AAG was injected intraperitoneally into nude mice bearing LuCaP35 xenograft tumors to determine the effect of HSP90 inhibition on prostate cancer progression to castration resistance and host survival. RESULTS: Administration of 17-AAG maintained androgen-sensitivity, delayed the progression of LuCaP35 xenograft tumors to castration resistance, and prolonged the survival of host. In addition, 17-AAG prevented nuclear localization of endogenous AR in LuCaP35 xenograft tumors in castrated nude mice. CONCLUSIONS: Targeting Hsp90 or the mechanism by which HSP90 regulates androgen-independent AR nuclear localization and activation may lead to new approaches to prevent and/or treat castration-resistant prostate cancer.
Authors: David B Solit; Fuzhong F Zheng; Maria Drobnjak; Pamela N Münster; Brian Higgins; David Verbel; Glenn Heller; William Tong; Carlos Cordon-Cardo; David B Agus; Howard I Scher; Neal Rosen Journal: Clin Cancer Res Date: 2002-05 Impact factor: 12.531
Authors: C P Webb; C D Hose; S Koochekpour; M Jeffers; M Oskarsson; E Sausville; A Monks; G F Vande Woude Journal: Cancer Res Date: 2000-01-15 Impact factor: 12.701
Authors: Khalid Z Masoodi; Raquel Ramos Garcia; Laura E Pascal; Yujuan Wang; Hei M Ma; Katherine O'Malley; Kurtis Eisermann; Daniel H Shevrin; Holly M Nguyen; Robert L Vessella; Joel B Nelson; Rahul A Parikh; Zhou Wang Journal: Endocrinology Date: 2013-05-13 Impact factor: 4.736
Authors: Javid A Dar; Khalid Z Masoodi; Kurtis Eisermann; Sudhir Isharwal; Junkui Ai; Laura E Pascal; Joel B Nelson; Zhou Wang Journal: J Steroid Biochem Mol Biol Date: 2014-03-22 Impact factor: 4.292
Authors: Manish K Thakur; Lance K Heilbrun; Shijie Sheng; Mark Stein; Glenn Liu; Emmanuel S Antonarakis; Ulka Vaishampayan; Sijana H Dzinic; Xiaohua Li; Stacy Freeman; Daryn Smith; Elisabeth I Heath Journal: Invest New Drugs Date: 2015-11-18 Impact factor: 3.850
Authors: Roberta Ferraldeschi; Jonathan Welti; Marissa V Powers; Wei Yuan; Tomoko Smyth; George Seed; Ruth Riisnaes; Somaieh Hedayat; Hannah Wang; Mateus Crespo; Daniel Nava Rodrigues; Ines Figueiredo; Susana Miranda; Suzanne Carreira; John F Lyons; Swee Sharp; Stephen R Plymate; Gerhardt Attard; Nicola Wallis; Paul Workman; Johann S de Bono Journal: Cancer Res Date: 2016-05-01 Impact factor: 12.701
Authors: Suqin He; Chaohua Zhang; Ayesha A Shafi; Manuel Sequeira; Jaime Acquaviva; Julie C Friedland; Jim Sang; Donald L Smith; Nancy L Weigel; Yumiko Wada; David A Proia Journal: Int J Oncol Date: 2012-11-14 Impact factor: 5.650
Authors: Joanna L Gillis; Luke A Selth; Margaret M Centenera; Scott L Townley; Shihua Sun; Stephen R Plymate; Wayne D Tilley; Lisa M Butler Journal: Oncotarget Date: 2013-05